These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
287 related items for PubMed ID: 1361883
21. Ras oncogene activation during hepatocarcinogenesis in B6C3F1 male mice by dichloroacetic and trichloroacetic acids. Ferreira-Gonzalez A, DeAngelo AB, Nasim S, Garrett CT. Carcinogenesis; 1995 Mar; 16(3):495-500. PubMed ID: 7697804 [Abstract] [Full Text] [Related]
22. Polymerase chain reaction/sequencing analysis of ras mutations in paraffin-embedded tissues as compared with 3T3 transfection and polymerase chain reaction/sequencing of frozen tumor deoxyribonucleic acids. Goodrow TL, Prahalada SR, Storer RD, Manam SV, Leander KR, Kraynak AR, van Zwieten MJ, Nichols WW, Bradley MO. Lab Invest; 1992 Apr; 66(4):504-11. PubMed ID: 1583889 [Abstract] [Full Text] [Related]
24. Mutagenesis of ras proto-oncogenes in rat liver tumors induced by vinyl chloride. Froment O, Boivin S, Barbin A, Bancel B, Trepo C, Marion MJ. Cancer Res; 1994 Oct 15; 54(20):5340-5. PubMed ID: 7923162 [Abstract] [Full Text] [Related]
26. Susceptibility of transgenic mice carrying human prototype c-Ha-ras gene in a short-term carcinogenicity study of vinyl carbamate and ras gene analyses of the induced tumors. Mitsumori K, Wakana S, Yamamoto S, Kodama Y, Yasuhara K, Nomura T, Hayashi Y, Maronpot RR. Mol Carcinog; 1997 Nov 15; 20(3):298-307. PubMed ID: 9397190 [Abstract] [Full Text] [Related]
27. Genetic alterations in the 61st codon of the H-ras oncogene isolated from archival sections of hepatic hyperplasias, adenomas and carcinomas in control groups of B6C3F1 mouse bioassay studies conducted from 1979 to 1986. Richardson KK, Helvering LM, Copple DM, Rexroat MA, Linville DW, Engelhardt JA, Todd GC, Richardson FC. Carcinogenesis; 1992 Jun 15; 13(6):935-41. PubMed ID: 1350949 [Abstract] [Full Text] [Related]
30. Mutations in the ras proto-oncogene: clues to etiology and molecular pathogenesis of mouse liver tumors. Maronpot RR, Fox T, Malarkey DE, Goldsworthy TL. Toxicology; 1995 Aug 25; 101(3):125-56. PubMed ID: 7676462 [Abstract] [Full Text] [Related]
31. Point mutations of the c-H-ras gene in spontaneous liver tumors of transgenic mice carrying the human c-H-ras gene. Hayashi S, Mori I, Nonoyama T, Mitsumori K. Toxicol Pathol; 1998 Aug 25; 26(4):556-61. PubMed ID: 9715515 [Abstract] [Full Text] [Related]
35. Differential DNase I hypersensitivity of ras oncogenes in B6C3F1, C3H/He, and C57BL/6 mouse liver. Vorce RL, Goodman JI. J Toxicol Environ Health; 1991 Nov 25; 34(3):385-95. PubMed ID: 1942124 [Abstract] [Full Text] [Related]
36. Dose-related changes in the profile of ras mutations in chemically induced CD-1 mouse liver tumors. Manam S, Shinder GA, Joslyn DJ, Kraynak AR, Hammermeister CL, Leander KR, Ledwith BJ, Prahalada S, van Zwieten MJ, Nichols WW. Carcinogenesis; 1995 May 25; 16(5):1113-9. PubMed ID: 7767973 [Abstract] [Full Text] [Related]
37. H- and K-ras mutational profiles in chemically induced liver tumors from B6C3F1 and CD-1 mice. Manjanatha MG, Li EE, Fu PP, Heflich RH. J Toxicol Environ Health; 1996 Feb 09; 47(2):195-208. PubMed ID: 8598575 [Abstract] [Full Text] [Related]
38. Parental bias of Ki-ras oncogenes detected in lung tumors from mouse hybrids. You M, Wang Y, Stoner G, You L, Maronpot R, Reynolds SH, Anderson M. Proc Natl Acad Sci U S A; 1992 Jul 01; 89(13):5804-8. PubMed ID: 1352876 [Abstract] [Full Text] [Related]
40. Additional evidence that the K-ras protooncogene is a candidate for the major mouse pulmonary adenoma susceptibility (Pas-1) gene. Lin L, Festing MF, Devereux TR, Crist KA, Christiansen SC, Wang Y, Yang A, Svenson K, Paigen B, Malkinson AM, You M. Exp Lung Res; 1998 Jul 01; 24(4):481-97. PubMed ID: 9659579 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]